These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34458829)

  • 1. Direct targeting of TDP-43, from small molecules to biologics: the therapeutic landscape.
    Francois-Moutal L; Scott DD; Khanna M
    RSC Chem Biol; 2021 Aug; 2(4):1158-1166. PubMed ID: 34458829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VMY; Lee EB; Hansson O
    Brain; 2023 Jul; 146(7):2975-2988. PubMed ID: 37150879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAR DNA-binding protein of 43 kDa (TDP-43) and amyotrophic lateral sclerosis (ALS): a promising therapeutic target.
    Ojaimi YA; Dangoumau A; Alarcan H; Hergesheimer R; Vourc'h P; Corcia P; Lanznaster D; Blasco H
    Expert Opin Ther Targets; 2022 Jun; 26(6):575-592. PubMed ID: 35652285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.
    Johnson BS; McCaffery JM; Lindquist S; Gitler AD
    Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6439-44. PubMed ID: 18434538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated TAR DNA-binding protein-43: Aggregation and antibody-based inhibition.
    Esposto JC; Martic S
    Biochim Biophys Acta Mol Basis Dis; 2021 Dec; 1867(12):166234. PubMed ID: 34339840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin B12 Reduces TDP-43 Toxicity by Alleviating Oxidative Stress and Mitochondrial Dysfunction.
    Jeon YM; Kwon Y; Lee S; Kim S; Jo M; Lee S; Kim SR; Kim K; Kim HJ
    Antioxidants (Basel); 2021 Dec; 11(1):. PubMed ID: 35052586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies.
    Young AL; Vogel JW; Robinson JL; McMillan CT; Ossenkoppele R; Wolk DA; Irwin DJ; Elman L; Grossman M; Lee VM; Lee EB; Hansson O
    medRxiv; 2023 Feb; ():. PubMed ID: 36778217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glial TDP-43 and TDP-43 induced glial pathology, focus on neurodegenerative proteinopathy syndromes.
    Prater KE; Latimer CS; Jayadev S
    Glia; 2022 Feb; 70(2):239-255. PubMed ID: 34558120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting TDP-43 proteinopathy with drugs and drug-like small molecules.
    Buratti E
    Br J Pharmacol; 2021 Mar; 178(6):1298-1315. PubMed ID: 32469420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PABPN1 suppresses TDP-43 toxicity in ALS disease models.
    Chou CC; Alexeeva OM; Yamada S; Pribadi A; Zhang Y; Mo B; Williams KR; Zarnescu DC; Rossoll W
    Hum Mol Genet; 2015 Sep; 24(18):5154-73. PubMed ID: 26130692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy.
    Khalil B; Chhangani D; Wren MC; Smith CL; Lee JH; Li X; Puttinger C; Tsai CW; Fortin G; Morderer D; Gao J; Liu F; Lim CK; Chen J; Chou CC; Croft CL; Gleixner AM; Donnelly CJ; Golde TE; Petrucelli L; Oskarsson B; Dickson DW; Zhang K; Shorter J; Yoshimura SH; Barmada SJ; Rincon-Limas DE; Rossoll W
    Mol Neurodegener; 2022 Dec; 17(1):80. PubMed ID: 36482422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis.
    Prasad A; Bharathi V; Sivalingam V; Girdhar A; Patel BK
    Front Mol Neurosci; 2019; 12():25. PubMed ID: 30837838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
    Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
    J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis.
    Kim HC; Zhang Y; King PH; Lu L
    J Neurochem; 2023 Mar; 164(5):643-657. PubMed ID: 36527420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.
    Trist BG; Fifita JA; Hogan A; Grima N; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Blair IP; Double KL
    Acta Neuropathol Commun; 2022 Aug; 10(1):122. PubMed ID: 36008843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice.
    Becker LA; Huang B; Bieri G; Ma R; Knowles DA; Jafar-Nejad P; Messing J; Kim HJ; Soriano A; Auburger G; Pulst SM; Taylor JP; Rigo F; Gitler AD
    Nature; 2017 Apr; 544(7650):367-371. PubMed ID: 28405022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TDP-43 proteinopathies, toward understanding of the molecular pathogenesis].
    Hasegawa M; Nonaka T; Yamashita M; Kametani F; Arai T; Yoshida M; Hashizume Y; Tsuchiya K; Akiyama H
    Rinsho Shinkeigaku; 2009 Nov; 49(11):783-5. PubMed ID: 20030209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies.
    Jo M; Lee S; Jeon YM; Kim S; Kwon Y; Kim HJ
    Exp Mol Med; 2020 Oct; 52(10):1652-1662. PubMed ID: 33051572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel monoclonal antibodies targeting the RRM2 domain of human TDP-43 protein.
    Trejo-Lopez JA; Sorrentino ZA; Riffe CJ; Lloyd GM; Labuzan SA; Dickson DW; Yachnis AT; Prokop S; Giasson BI
    Neurosci Lett; 2020 Nov; 738():135353. PubMed ID: 32905837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis.
    Suk TR; Rousseaux MWC
    Mol Neurodegener; 2020 Aug; 15(1):45. PubMed ID: 32799899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.